z-logo
open-access-imgOpen Access
HISTOCHEMICAL, IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL INVESTIGATIONS OF GIANT CELL TUMORS OF BONE
Author(s) -
Emura Iwao,
Inoue Yoshiya,
Ohnishi Yoshihisa,
Morita Tetsuro,
Saito Hidehiko,
Tajima Tatsuya
Publication year - 1986
Publication title -
acta patholigica japonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
ISSN - 0001-6632
DOI - 10.1111/j.1440-1827.1986.tb01057.x
Subject(s) - stromal cell , pathology , giant cell , histiocyte , bone marrow , giant cell tumor of bone , immunohistochemistry , mesenchymal stem cell , osteoclast , osteoid , chemistry , giant cell tumors , lymph node stromal cell , biology , medicine , biochemistry , in vitro
The origin and characteristics of so‐called stromal cells (stromal cell) and the osteoclast‐like giant cell series of 19 cases of giant cell tumor (G.C.T.) of bone were studied. Immunohistochemically, two interesting cases were found. The stromal cells of one case were α‐1‐antitrypsin positive and those of the other case were α‐1‐antichymotrypsin positive. The histiocytic stromal cells of the latter case seemed to be surely neoplastic since they showed mild to moderate cell atypism. There were foci consisting of fibroblastic cells or osteoid and osteoblasts within the tumor. Those cells in the foci were apparently continuous with the surrounding stromal cells, and they were, therefore, also considered to be neoplastic. These findings strongly indicate that the stromal cells originate from the undifferentiated mesenchymal cells in the bone marrow and may differentiate to osteoblastic, fibroblastic, and histiocytic cells. All cells of these three series were not stained for a high stable form of acid phosphatase (SAPhase). SAPhase activity was demonstrated only in osteoclast‐like giant cells and some mononuclear cells, which are recently believed to be non‐neoplastic. Therefore, the cell atypia of SAPhase negative stromal cells is considered to have a prognostic value.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here